IDiyas

For the Inventor, By the Inventor

Chestnut Hill, MA, United States of America

William R Sellers

USPTO Granted Patents = 13


 

Average Co-Inventor Count = 6.5

ph-index = 7

Forward Citations = 606(Granted Patents)


Location History:

  • Brookline, MA (US) (1998 - 2011)
  • Chestnut Hill, MA (US) (2005 - 2024)

Company Filing History:

goldMedal13 out of 1,206 
 
Dana-farber-cancer Institute Inc.
 patents
silverMedal8 out of 2,882 
 
The General Hospital Corporation
 patents
bronzeMedal2 out of 303 
 
Whitehead Institute for Biomedical Research
 patents
4. 1 out of 1,370 
 
The Brigham and Women's Hospital, Inc.
 patents
where one patent can have more than one assignee

Years Active: 1998-2024

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 12006555 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (2024-06-11),
2. 10669589 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (2020-06-02),
3. 10000815 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (2018-06-19),
4. 9035036 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (2015-05-19),
5. 8465916 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (2013-06-18),
6. 8105769 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (2012-01-31),
7. 7981609 - Methods for identifying and using SNP panels (2011-07-19),
8. 7964349 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (2011-06-21),
9. 7501248 - Prostate cancer diagnosis and outcome prediction by expression analysis (2009-03-10),
10. 7294468 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (2007-11-13),
11. 6949342 - Prostate cancer diagnosis and outcome prediction by expression analysis (2005-09-27),
12. 5981723 - Retinoblastoma-associated protein 1 CDNA (1999-11-09),
13. 5759803 - Recombinant retinoblastoma-associated protein 1 (E2F-1) polypeptides and (1998-06-02),
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…